Clorox Company (The) (CLX) Stake Maintained by Whittier Trust Co.

Whittier Trust Co. continued to hold its stake in Clorox Company (The) (NYSE:CLX) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,341 shares of the company’s stock at the end of the second quarter. Whittier Trust Co.’s holdings in Clorox Company (The) were worth $712,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Korea Investment CORP increased its stake in Clorox Company (The) by 938.9% in the first quarter. Korea Investment CORP now owns 178,197 shares of the company’s stock valued at $24,026,000 after buying an additional 161,044 shares during the period. Crossvault Capital Management LLC increased its stake in Clorox Company (The) by 3.8% in the first quarter. Crossvault Capital Management LLC now owns 34,684 shares of the company’s stock valued at $4,676,000 after buying an additional 1,285 shares during the period. Park National Corp OH increased its stake in Clorox Company (The) by 6.5% in the first quarter. Park National Corp OH now owns 5,440 shares of the company’s stock valued at $733,000 after buying an additional 331 shares during the period. HighPoint Advisor Group LLC increased its stake in Clorox Company (The) by 3.0% in the fourth quarter. HighPoint Advisor Group LLC now owns 43,247 shares of the company’s stock valued at $5,509,000 after buying an additional 1,245 shares during the period. Finally, Ameriprise Financial Inc. increased its stake in Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock valued at $146,932,000 after buying an additional 25,110 shares during the period. Institutional investors and hedge funds own 69.83% of the company’s stock.

Clorox Company (NYSE:CLX) traded up 0.41% during trading on Friday, hitting $137.73. The stock had a trading volume of 734,445 shares. The company has a 50-day moving average of $133.55 and a 200-day moving average of $134.12. The stock has a market capitalization of $17.78 billion, a P/E ratio of 25.82 and a beta of 0.40. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm’s quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter last year, the company earned $1.30 earnings per share. On average, equities analysts expect that Clorox Company will post $5.67 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Clorox Company (The) (CLX) Stake Maintained by Whittier Trust Co.” was posted by BNB Daily and is the property of of BNB Daily. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.baseball-news-blog.com/2017/08/19/whittier-trust-co-has-712000-position-in-clorox-company-the-clx-updated-updated-updated.html.

Several analysts recently issued reports on CLX shares. Deutsche Bank AG restated a “hold” rating and issued a $137.00 price target (up from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. Vetr upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 price target for the company in a research note on Monday, April 24th. BMO Capital Markets restated a “buy” rating and issued a $136.00 price target on shares of Clorox Company (The) in a research note on Thursday, May 4th. Zacks Investment Research downgraded Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Finally, BidaskClub downgraded Clorox Company (The) from a “sell” rating to a “strong sell” rating in a research note on Monday, July 24th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply